Pharmacological enhancement of behavioral therapy: Focus on posttraumatic stress disorder

32Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

You may have access to this PDF.

Abstract

Improved efficacy in the treatment of posttraumatic stress disorder (PTSD) and other anxiety disorders is urgently needed. Traditional anxiety treatments of hypnosis and psychodynamic therapy may be of some help, but uncontrolled studies lead to inconclusive results on the efficacy of these treatment techniques. There is a larger literature supporting the efficacy of cognitive-behavioral procedures with PTSD, including prolonged exposure therapy, eye movement desensitization and reprocessing, and anxiety management techniques. The cutting-edge technology of virtual reality-based exposure therapy for PTSD is particularly exciting. To further build on effective psychosocial treatments, current pharmacological augmentation approaches to emotional learning are being combined with psychotherapy. In particular, D-cycloserine, a partial NMDA agonist, has shown to be effective in facilitating the exposure/extinction therapy to improve the efficacy of treating anxiety disorders, and may guide the way for new pharmacological enhancements of behavioral therapy. © Springer-Verlag Berlin Heidelberg 2009.

Cite

CITATION STYLE

APA

Choi, D. C., Rothbaum, B. O., Gerardi, M., & Ressler, K. J. (2010). Pharmacological enhancement of behavioral therapy: Focus on posttraumatic stress disorder. Current Topics in Behavioral Neurosciences, 2, 279–299. https://doi.org/10.1007/7854_2009_10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free